Clinical Trials Browser

NETWORK × Uterine Cervical Dysplasia × Clear all

NCT00892866 2024-05-03

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Phase NA Active not recruiting

Uterine Cervical Dysplasia, Endometrial Hyperplasia, Papillomavirus Infections

NCT00667563 2024-03-19

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Phase 1 Completed

150 enrolled 12 charts

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions, HIV Infections, Papillomavirus Infections

NCT00577317 2021-06-23

Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer

Phase 3 Terminated

2 enrolled 5 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Lymphedema, Vulvar Neoplasms

NCT00003384 2015-05-29

Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

Phase NA Completed

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Precancerous Conditions

NCT00072540 2013-11-08

S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix

Phase 2 Withdrawn

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia